Stemline Therapeutics, Inc. to Present at the 12th Annual Needham Healthcare Conference on May 1, 2013
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
NEW YORK, April 25, 2013 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage biopharmaceutical company developing oncology therapeutics that target both cancer stem cells (CSCs) and tumor bulk, announced today that Ivan Bergstein, M.D., Chief Executive Officer, will present at the 12th Annual Needham Healthcare Conference on Wednesday, May 1, 2013 at 11:20 am ET. The conference will take place at the Westin New York Grand Central Hotel in New York, NY. A live webcast and 30-day archive of the event can be viewed at the Company's website at http://www.stemline.com.
Help employers find you! Check out all the jobs and post your resume.
NEW YORK, April 25, 2013 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage biopharmaceutical company developing oncology therapeutics that target both cancer stem cells (CSCs) and tumor bulk, announced today that Ivan Bergstein, M.D., Chief Executive Officer, will present at the 12th Annual Needham Healthcare Conference on Wednesday, May 1, 2013 at 11:20 am ET. The conference will take place at the Westin New York Grand Central Hotel in New York, NY. A live webcast and 30-day archive of the event can be viewed at the Company's website at http://www.stemline.com.
Help employers find you! Check out all the jobs and post your resume.